OpGen Announces Date of Second Quarter 2019 Financial Results Conference Call
July 30 2019 - 6:30AM
OpGen, Inc. (NASDAQ: OPGN) announced today
that the Company will report its second quarter 2019 financial
results after the close of the U.S. financial markets
on Wednesday, August 7, 2019. OpGen’s management team will
host a live conference call and audio webcast at 4:30 p.m.
Eastern Time to discuss the Company’s financial results and
business progress.
Dial-in Information U.S. Dial-In Number: (844)
420-8185
International Dial-In Number: (216)
562-0481
Conference ID: 7288909
Replay Dial-in Information U.S. Dial-In Number:
(855) 859-2056 International Dial-In Number:
(404) 537-3406 Conference ID: 7288909
Following the conclusion of the conference call, a replay will
be available through August 13, 2019. The live, listen-only
webcast of the conference call may also be accessed by visiting the
investors section of the Company’s website
at www.ir.opgen.com. A replay of the webcast
will be available after the conclusion of the call and will be
archived on the Company’s website for 90 days.
About
OpGen
OpGen, Inc. is a precision medicine company
harnessing the power of molecular diagnostics and informatics to
help combat infectious disease. We are developing molecular
information products and services for global healthcare settings,
helping to guide clinicians with more rapid and actionable
information about life threatening infections, improve patient
outcomes, and decrease the spread of infections caused by
multidrug-resistant microorganisms, or MDROs.
Our molecular diagnostics and informatics
products, product candidates and services combine our Acuitas
molecular diagnostics and Acuitas Lighthouse informatics platform
for use with our proprietary, curated MDRO knowledgebase. We are
working to deliver our products and services, some in development,
to a global network of customers and partners. The Acuitas AMR Gene
Panel (RUO) is intended for Research Use Only and is not for use in
diagnostic procedures. The Acuitas Lighthouse Software is not
distributed commercially for antibiotic resistance prediction and
is not for use in diagnostic procedures. For more information,
please visit www.opgen.com.
OpGen, Acuitas, and Acuitas Lighthouse are
registered trademarks of OpGen, Inc.
OpGen Contact: Michael Farmer Vice President,
Marketing (240) 813-1284 mfarmer@opgen.com
InvestorRelations@opgen.com
Press Contact: Matthew Bretzius
FischTank Marketing and PR
matt@fischtankpr.com
Investor Contacts: Joe Green Edison Group
jgreen@edisongroup.com
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Sep 2024 to Oct 2024
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Oct 2023 to Oct 2024